These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Unusual sites of Hodgkin's lymphoma: CASE 2. Hodgkin's lymphoma of the CNS masquerading as meningioma. Figueroa BE; Brown JR; Nascimento A; Fisher DC; Tuli S J Clin Oncol; 2004 Oct; 22(20):4228-30. PubMed ID: 15483035 [No Abstract] [Full Text] [Related]
4. [Meningeal involvement in non-Hodgkin's lymphoma]. Sato Y; Natori H; Motoori T; Egami K; Kaji M Rinsho Shinkeigaku; 1982 Nov; 22(11):1021-6. PubMed ID: 6984829 [No Abstract] [Full Text] [Related]
6. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease. Borowitz MJ; Croker BP; Metzgar RS Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433 [TBL] [Abstract][Full Text] [Related]
7. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499 [TBL] [Abstract][Full Text] [Related]
8. Quantitative ultrastructural analysis of in vivo lymphocyte-Reed-Sternberg cell interactions in Hodgkin's disease. Archibald RB; Frenster JH Natl Cancer Inst Monogr; 1973 May; 36():239-45. PubMed ID: 4542772 [No Abstract] [Full Text] [Related]
9. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease. Berard CW Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349 [No Abstract] [Full Text] [Related]
11. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease. Zółtowska A; Arendt M; Gan J Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594 [TBL] [Abstract][Full Text] [Related]
12. Interfollicular Hodgkin's disease: an uncommon pattern that may cause diagnostic difficulty. Basu D; Roy SK Indian J Pathol Microbiol; 2006 Apr; 49(2):221-5. PubMed ID: 16933719 [TBL] [Abstract][Full Text] [Related]
13. T-polyagglutination in Hodgkin's disease. Buskila D; Levene C; Levene NA Isr J Med Sci; 1985 Jul; 21(7):621-3. PubMed ID: 3876319 [No Abstract] [Full Text] [Related]
14. Lymphocytic characterization in Hodgkin's and non-Hodgkin's lymphoma. Kamthan M; Joshi N; Sharma ML Indian J Pathol Microbiol; 1982 Apr; 25(2):139-43. PubMed ID: 6982850 [No Abstract] [Full Text] [Related]
15. [Intracranial localization of Hodgkin's disease. Apropos of 2 cases]. Constans JP; Castresana A; Meder JF; Vedrenne C; Cosset JM; Hayat M Bull Cancer; 1989; 76(3):301-10. PubMed ID: 2660941 [TBL] [Abstract][Full Text] [Related]
16. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. Armitage JO; Dick FR; Goeken JA; Foucar MK; Gingrich RD Arch Intern Med; 1983 Mar; 143(3):445-50. PubMed ID: 6338848 [TBL] [Abstract][Full Text] [Related]
17. Primary Hodgkin's disease of the falx cerebri. Nagashima K; Mori S; Yoshimasu N; Takahashi K Acta Neuropathol; 1980; 51(2):161-3. PubMed ID: 7435148 [TBL] [Abstract][Full Text] [Related]
18. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide. Fisher RI; Bostick-Bruton F J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949 [TBL] [Abstract][Full Text] [Related]
19. [Immunological characteristics of the peripheral blood and lymph node lymphocytes in Hodgkin's disease and reactive lymphadenitis]. Loginskiĭ VE; Polishchuk RS; Logoĭda DM Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):35-8. PubMed ID: 6969399 [No Abstract] [Full Text] [Related]
20. [Membrane immunoglobulins in peripheral blood lymphocytes in Hodgkin's disease]. Grifoni V; Del Giacco GS; Manconi PE; Tognella S Haematologica; 1972; 57(9):529-32. PubMed ID: 4199306 [No Abstract] [Full Text] [Related] [Next] [New Search]